SH-273

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameSH-273
Drug Alias NameNano-273SH-273
ClassificationSmall molecules
Mechanisms of ActionStimulator of interferon genes stimulantsDendritic cells stimulantsT lymphocytes stimulants +[5] 
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gammaStimulator of interferon genes
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A